Tumor LAG ‐3 and NY‐ESO ‐1 expression predict durable clinical benefits of immune checkpoint inhibitors in advanced non‐small cell lung cancer
Journal article published in 2021 by
Eun Hee Jung 
,
Hee Ryeong Jang,
Se Hyun Kim ,
Koung Jin Suh,
Yu Jung Kim ,
Ju‐Hyun Lee ,
Jin‐Haeng Chung,
Miso Kim ,
Bhumsuk Keam ,
Tae Min Kim,
Dong‐Wan Kim ,
Dae Seog Heo,
Jong Seok Lee
,
Hee Ryeong Jang,
Se Hyun Kim ,
Koung Jin Suh,
Yu Jung Kim ,
Ju‐Hyun Lee ,
Jin‐Haeng Chung,
Miso Kim ,
Bhumsuk Keam ,
Tae Min Kim,
Dong‐Wan Kim ,
Dae Seog Heo,
Jong Seok Lee
This paper is made freely available by the publisher.
Full text: Download
Data provided by 